Agenus Inc. (Nasdaq: AGEN) has acquired biopharmaceutical company 4-Antibody AG.
The target develops the Retrocyte Display technology platform, which aims to help regulate immune response to cancers and other diseases.
Complete access to real-time information and analysis of news and trends in the industry.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In